Myriad Genetics Stock Probability of Future Stock Price Finishing Over 15.12
| MYGN Stock | USD 15.12 0.18 1.18% |
Myriad |
Myriad Genetics Target Price Odds to finish over 15.12
The tendency of Myriad Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.12 | 90 days | 15.12 | about 97.0 |
Based on a normal probability distribution, the odds of Myriad Genetics to move above the current price in 90 days from now is about 97.0 (This Myriad Genetics probability density function shows the probability of Myriad Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Myriad Genetics has a beta of 0.56. This indicates as returns on the market go up, Myriad Genetics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Myriad Genetics will be expected to be much smaller as well. Additionally Myriad Genetics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Myriad Genetics Price Density |
| Price |
Predictive Modules for Myriad Genetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Myriad Genetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Myriad Genetics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Myriad Genetics is not an exception. The market had few large corrections towards the Myriad Genetics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Myriad Genetics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Myriad Genetics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.93 | |
β | Beta against Dow Jones | 0.56 | |
σ | Overall volatility | 4.42 | |
Ir | Information ratio | -0.28 |
Myriad Genetics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Myriad Genetics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Myriad Genetics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Myriad Genetics generated a negative expected return over the last 90 days | |
| Myriad Genetics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 753.2 M. Net Loss for the year was (263.3 M) with profit before overhead, payroll, taxes, and interest of 476.4 M. | |
| Myriad Genetics currently holds about 205.1 M in cash with (110.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.54. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from forbes.com: The Myriad Leader Shifting The Way We Think About Leadership |
Myriad Genetics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Myriad Stock often depends not only on the future outlook of the current and potential Myriad Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Myriad Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 89.9 M |
Myriad Genetics Technical Analysis
Myriad Genetics' future price can be derived by breaking down and analyzing its technical indicators over time. Myriad Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Myriad Genetics. In general, you should focus on analyzing Myriad Stock price patterns and their correlations with different microeconomic environments and drivers.
Myriad Genetics Predictive Forecast Models
Myriad Genetics' time-series forecasting models is one of many Myriad Genetics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Myriad Genetics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Myriad Genetics
Checking the ongoing alerts about Myriad Genetics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Myriad Genetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Myriad Genetics generated a negative expected return over the last 90 days | |
| Myriad Genetics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 753.2 M. Net Loss for the year was (263.3 M) with profit before overhead, payroll, taxes, and interest of 476.4 M. | |
| Myriad Genetics currently holds about 205.1 M in cash with (110.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.54. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from forbes.com: The Myriad Leader Shifting The Way We Think About Leadership |
Check out Myriad Genetics Backtesting, Myriad Genetics Valuation, Myriad Genetics Correlation, Myriad Genetics Hype Analysis, Myriad Genetics Volatility, Myriad Genetics History as well as Myriad Genetics Performance. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 9.205 | Quarterly Revenue Growth 0.112 | Return On Assets (0.05) | Return On Equity (0.16) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.